Aron E. Kefela, MD

Northwest Georgia Oncology Centers, P.C. Paulding Cancer Center 144 Bill Carruth Pkwy.
Suite 3100
Hiram, GA 30141
Phone: (678) 363-1940
Fax: (678) 581-7100

Douglasville Cancer Center 6002 Professional Parkway
Suite 220
Douglasville, GA 30134
Phone: (678) 715-9690
Fax: (678) 581-7140

Aron E. Kefela, MD joined the cancer care team of Northwest Georgia Oncology Centers, P.C. (NGOC) in August 2014. Dr. Kefela treats all forms of cancer and blood disorders with a special interest in breast cancer.  He completed his Fellowship in Hematology and Medical Oncology at Allegheny Health Network, Temple University in Pittsburgh, PA in June 2014 and completed his Internship and Residency in Internal Medicine at St. Vincent Hospital in Indianapolis, IN in 2009.   Dr. Kefela received his Doctorate of Medicine from Indiana University School of Medicine in Indianapolis, IN.

He is actively involved in cancer research and clinical trials to find a cancer cure and provide patients with the most advanced cancer treatment available in Georgia.

Dr. Kefela provides patient-centered cancer care at NGOC’s Paulding Cancer Center and Douglasville Cancer Center.

Personal DataBirthplace: Evanston, IL
Undergraduate EducationWayne State University
Detroit, MI

Indiana University, School of Medicine
Indianapolis, IN
Medical EducationDoctor of Medicine
Indiana University, School of Medicine
Indianapolis, IN
May 2006
Postdoctoral TrainingINTERNSHIP
Internal Medicine
St. Vincent Hospital
Indianapolis, IN
July 2006 - June 2007

Internal Medicine
St. Vincent Hospital
Indianapolis, IN
July 2007- June 2009

Hematology & Medical Oncology
Allegheny Health Network, Temple University
Pittsburgh, PA
July 2011 – June 2014
Board CertificationAmerican Board of Internal Medicine, Internal Medicine, 2010
American Board of Internal Medicine, Medical Oncology, 2014
American Board of Internal Medicine, Hematology, 2018
Medical LicensureState of Georgia, 2014
Professional SocietiesAmerican Society of Clinical Oncology
American Society of Hematology
National Cancer Institute
HonorsDepartment of Clinical Laboratory Science Scholarship, 1999
Dean's List, 1996-1999
MB Andrews, FA Greco, DH Johnson, JD Hainsworth. "Mitoxantrone, FU, and High Dose Leucovorin: An Effective Well Tolerated Regimen For Refractory Breast Cancer. ASCO Proceedings". Volume 9: 35, March 1990.

JD Hainsworth, MB Andrews, DH Johnson, FA Greco. "Mitoxantrone, Fluorouracil, and High Regimen for Metastatic Breast Cancer". Journal of Clinical Oncology, Volume 9: 1731-1735, October 1991.
JD Hainsworth, S Litchy, L Morrissey, MB Andrews, MGrimaldi, M McCarty, FA Greco. “Rituximab Plus Short – Duration Chemotherapy As First – Line Treatment for Follicular Non-Hodgkin’s Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network. Journal of Clinical Oncology, Page 1500-1506, March 2005.
Research ActivityClinical Trials (Oncology & Hematology)

-Retrospective study of safety and efficacy of Flu/BU/TBI conditioning regimen in allogeneic stem cell transplantation, July 2012-present.

-Retrospective review of outcome of patients with early stage HER2/Neu positive breast cancer (Stage 1, T1a, T1b) who received Herceptin vs. those who did not, March 2013-present.

-Accuracy of MRI vs. mammography in the evaluation of patients who received neoadjuvant treatment in minimally invasive breast cancer, August 2009-December 2009. Presented poster in ASBD Annual Symposium, New York, 2010.